TY - CHAP M1 - Book, Section TI - Chapter 34. Thrombotic Microangiopathies A1 - Nast, Cynthia C. A1 - Adler, Sharon G. A2 - Lerma, Edgar V. A2 - Berns, Jeffrey S. A2 - Nissenson, Allen R. Y1 - 2009 N1 - T2 - CURRENT Diagnosis & Treatment: Nephrology & Hypertension AB - The thrombotic microangiopathies (TMAs) are classified together due to their overlapping clinical and morphologic findings. Their major clinical manifestations include hemolytic anemia, microvascular thrombosis, and thrombocytopenia. Most TMAs have renal involvement with similar morphologic changes in the kidney reflecting the vasculopathy these lesions share. There are a number of underlying etiologic factors inducing TMA including systemic diseases, infection, and medications, which are summarized in Table 34–1. SN - PB - The McGraw-Hill Companies CY - New York, NY Y2 - 2024/10/04 UR - accessmedicine.mhmedical.com/content.aspx?aid=6336929 ER -